El Sorogy, H.M.; Fayez, S.M.; Khalil, I.A.; Abdel Jaleel, G.A.; Fayez, A.M.; Eliwa, H.A.; Teba, H.E.
Microporation-Mediated Transdermal Delivery of In Situ Gel Incorporating Etodolac-Loaded PLGA Nanoparticles for Management of Rheumatoid Arthritis. Pharmaceutics 2024, 16, 844.
https://doi.org/10.3390/pharmaceutics16070844
AMA Style
El Sorogy HM, Fayez SM, Khalil IA, Abdel Jaleel GA, Fayez AM, Eliwa HA, Teba HE.
Microporation-Mediated Transdermal Delivery of In Situ Gel Incorporating Etodolac-Loaded PLGA Nanoparticles for Management of Rheumatoid Arthritis. Pharmaceutics. 2024; 16(7):844.
https://doi.org/10.3390/pharmaceutics16070844
Chicago/Turabian Style
El Sorogy, Heba M., Sahar M. Fayez, Islam A. Khalil, Gehad A. Abdel Jaleel, Ahmed M. Fayez, Hesham A. Eliwa, and Hoda E. Teba.
2024. "Microporation-Mediated Transdermal Delivery of In Situ Gel Incorporating Etodolac-Loaded PLGA Nanoparticles for Management of Rheumatoid Arthritis" Pharmaceutics 16, no. 7: 844.
https://doi.org/10.3390/pharmaceutics16070844
APA Style
El Sorogy, H. M., Fayez, S. M., Khalil, I. A., Abdel Jaleel, G. A., Fayez, A. M., Eliwa, H. A., & Teba, H. E.
(2024). Microporation-Mediated Transdermal Delivery of In Situ Gel Incorporating Etodolac-Loaded PLGA Nanoparticles for Management of Rheumatoid Arthritis. Pharmaceutics, 16(7), 844.
https://doi.org/10.3390/pharmaceutics16070844